KFDA to specify scope of stability test data for new and generic drugs.

Published: 2005-08-11 06:55:00

Updated: 2005-08-11 06:55:00

The KFDA Drug Safety Bureau and Drug Review Department announced a unified standard to define the scope of stability test data required for a new and generic drug registration through "Pharmaceutical Regulatory Standards Study Council"

The new standards clearly defined the required stability t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK